Theseus Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Theseus Pharmaceuticals.

Price Target: $ (0.00%)

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Theseus Pharmaceuticals.

Recommendation Trends

Rating	Apr '24	May '24
Strong Buy	0	0
Buy	1	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bruce Jackson Benchmark	Benchmark	Buy Reiterates $1	Buy	Reiterates	$1	-54.95%	May 29, 2024
Bruce Jackson Benchmark	Benchmark	Buy Initiates $1	Buy	Initiates	$1	-54.95%	Apr 8, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

6.06M

EPS This Year

-9.29

from -7.85

EPS Next Year

-10.91

from -9.29

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Sep 30, 2020	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026
Revenue	121.94K	-	4.36M	-	-	-	6.06M
Revenue Growth	-93.24%	-	-	-	-	-	-
EPS	-24.90	-34.54	-19.89	-16.49	-7.85	-9.29	-10.91
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	6.3M
Avg	n/a	6.1M
Low	n/a	5.9M

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-9.66	-11.34
Avg	-9.29	-10.91
Low	-9.02	-10.58

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.